Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global molecular switches market was valued at USD 677.30 Million in 2023. It is expected to grow at a CAGR of 11.03% during the forecast period of 2024-2032 and attain a market value of USD 1736.78 Million by 2032. The patents for molecular switches are rapidly increasing as a result of the growing application of gene switches in a range of therapeutic sectors, as well as increased investment in biotechnology and pharmaceutical research. Furthermore, the development of medical devices.
The Global Molecular Switches Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for molecular switches include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with Molecular Switches. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within molecular switch technologies.
An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for molecular switch technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with molecular switches.
A comprehensive summary of several patent applications which were filed across different jurisdictions for molecular switches and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.
Detailed analysis of the granted patents across different jurisdictions for molecular switches and their relative value in the IP are covered in the final report.
Molecular switches also known as gene switches, are critical components of genetic circuits with numerous applications in synthetic biology, gene therapy, and developmental biology. Gene switch platforms are commonly used to improve the safety of modified T-cell therapies, such as CAR T-cell therapy, by including a reversible ON/OFF safety switch. Several studies are currently being conducted to test small molecule-based safety switches for a variety of cell-based therapies. Furthermore, gene switch platforms are utilized to control transgene expression in a variety of gene therapies, eliminating the need for extra protein components.
The gene switch is a location on a gene where regulatory molecules can bind to initiate the transcription and translational processes that result in gene expression. Gene switching is defined as the reversible on/off switching of gene expression or the switching of expression between two alleles of the same gene. Any gene's expression is determined by its rate of transcription into mRNA and translation into proteins. The transcription rate is regulated by specific regulatory proteins, often known as transcription factors. Gene switches can be regulatory proteins or specific DNA sequences that activate or inhibit gene expression. The molecular switch has been shown effective in overcoming the adverse effects associated with adoptive cell treatment.
Growing Demand for Molecular Switches in Personalized Medicine is Expected to Boost the Patent Industry Growth
Molecular switching can be used to tailor therapy based on a patient's genetic composition and the specific aspects of their condition. This is becoming increasingly relevant as personalized medicine develops. The gene switch industry is expanding due to the increased need for personalized medicine. Gene switches are critical for fine-tuning these individualized medicines. Gene switches can turn certain genes on or off in response to various situations or therapy. Healthcare practitioners and pharmaceutical corporations are increasingly understanding the importance of gene switches in enhancing therapy success and lowering adverse effects.
Rising Usage of Gene Switch Platforms is Expected to Propel Molecular Switches Patent Industry Demand
The molecular switch patent industry is growing due to the increased use of gene switch platforms. This is especially true for the cell-based therapy businesses. Cell-based treatments, such as CAR-T, have enormous potential for treating a variety of disorders. They also raise substantial safety and efficacy concerns. As the number of cell-based therapeutics increases, so will the demand for gene switch platforms that address these critical safety and effectiveness concerns.
The report will cover the following sections in detail:
Analysis by Product Type
Analysis by Indication
The breakup based on product type includes monoclonal antibodies, cytokines, and antibody-cytokine fusion proteins. The cytokines segment is expected to lead the patent applications during the forecast period, owing to the growing use of cytokines driven by their key roles in cellular signalling and immune responses. This integration enhances targeted drug delivery systems, improves diagnostic tools by acting as biomarkers, and facilitates immune modulation for therapies like cancer immunotherapy. The combination of cytokines with nanotechnology is also leading to more effective and dynamic delivery systems.
The United States is one of the leading jurisdictions for molecular switch patents, having around 402,700+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.
Among the players with molecular switches patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the molecular switches field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
Sangamo Biosciences is a biotechnology company focused on developing genomic therapies for various genetic diseases and disorders. Founded in 1995 and headquartered in Richmond, California, Sangamo is a pioneer in gene editing technologies, particularly using zinc finger nucleases (ZFNs), transcription factors, and other proprietary platforms to precisely modify genes.
Gendaq Ltd. is a biotechnology company focused on developing advanced gene editing technologies and genomic so...
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Zeneca Ltd., Syngenta Limited, and Hoffmann La Roche, among others.
The Molecular Switches patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
Scope of the Report |
Details |
Analysis by Product Type |
|
Analysis by Indication |
|
Key Players Mentioned |
|
Geographies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share